Skip to main content
Erschienen in: Medical Oncology 2/2012

01.06.2012 | Original Paper

Prognostic value of hedgehog signaling pathway in patients with colon cancer

verfasst von: Meihua Xu, Xinhua Li, Ting Liu, Aimin Leng, Guiying Zhang

Erschienen in: Medical Oncology | Ausgabe 2/2012

Einloggen, um Zugang zu erhalten

Abstract

Hedgehog signaling pathway plays an important role in normal mammalian gastrointestinal development and is implicated in the oncogenesis of various tumors. However, its correlation with progression and prognosis of colon cancer has not been well documented. This study was designed to investigate expression patterns of related proteins in hedgehog signaling pathway in colon cancer to elucidate its prognostic value in this tumor. Using human colon cancer and their corresponding non-diseased colon from 228 patients’ biopsies, the expression of sonic hedgehog, its receptor Patched, and downstream transcription factor Gli1 was investigated by immunohistochemical staining to assess their association with the clinicopathological characteristics of colon cancer. Disease-free survival and overall survival were examined by Kaplan–Meier estimates and the log-rank test. Prognostic factors were determined by multivariate Cox analysis. One hundred and thirty-eight patients (59.6%) had sonic hedgehog-positive tumors and that the disease-free survival (43.5 vs. 73.3%, P < 0.001), and overall survival rates (50.7 vs. 88.9%, P < 0.001) of patients with sonic hedgehog-positive tumors were much lower than those of patients with sonic hedgehog-negative tumors. In addition, 163 patients (71.5%) had Patched-positive tumors, and the disease-free survival (41.7 vs. 76.9%, P < 0.001) and overall survival rates (55.2 vs. 80.0%, P = 0.002) of patients with Patched-positive tumors were also lower than those of patients with Patched-negative tumors. Moreover, positive Gli1 expression had a bad effect on the disease-free survival (41.9 vs. 73.2%, P < 0.001) and overall survival rate of patients with colon cancer (50.0 vs. 89.3%, P < 0.001). In a multivariate analysis, sonic hedgehog, Patched, and Gli1 status were indicators for poor disease-free survival and overall survival. These results have shown that the increasing expression of sonic hedgehog, Patched, and Gli1 are indicators for a poor prognosis in patients with colon cancer. This is the first report describing about the relationship between hedgehog signaling pathway and the prognosis of colon cancer.
Literatur
1.
Zurück zum Zitat Bai HL, Chen B, Zhou Y, Wu XT. Five-year long-term outcomes of laparoscopic surgery for colon cancer. World J Gastroenterol. 2010;16:4992–7.PubMedCrossRef Bai HL, Chen B, Zhou Y, Wu XT. Five-year long-term outcomes of laparoscopic surgery for colon cancer. World J Gastroenterol. 2010;16:4992–7.PubMedCrossRef
2.
Zurück zum Zitat Luglio G, Nelson H. Laparoscopy for colon cancer: state of the art. Surg Oncol Clin N Am. 2010;19:777–91.PubMedCrossRef Luglio G, Nelson H. Laparoscopy for colon cancer: state of the art. Surg Oncol Clin N Am. 2010;19:777–91.PubMedCrossRef
3.
Zurück zum Zitat Peng RQ, Wu XJ, Ding Y, Li CY, Yu XJ, Zhang X, et al. Co-expression of nuclear, cytoplasmic HMGB1 is inversely associated with infiltration of CD45RO+T cells, prognosis in patients with stage IIIB colon cancer. BMC Cancer. 2010;10:496.PubMedCrossRef Peng RQ, Wu XJ, Ding Y, Li CY, Yu XJ, Zhang X, et al. Co-expression of nuclear, cytoplasmic HMGB1 is inversely associated with infiltration of CD45RO+T cells, prognosis in patients with stage IIIB colon cancer. BMC Cancer. 2010;10:496.PubMedCrossRef
4.
Zurück zum Zitat Pasca di Magliano M, Hebrok M. Hedgehog signalling in cancer formation and maintenance. Nat Rev Cancer. 2003;3:903–11.PubMedCrossRef Pasca di Magliano M, Hebrok M. Hedgehog signalling in cancer formation and maintenance. Nat Rev Cancer. 2003;3:903–11.PubMedCrossRef
5.
Zurück zum Zitat Kameda C, Tanaka H, Yamasaki A. The Hedgehog pathway is a possible therapeutic target for patients with estrogen receptor-negative breast cancer. Anticancer Res. 2009;29:871–9.PubMed Kameda C, Tanaka H, Yamasaki A. The Hedgehog pathway is a possible therapeutic target for patients with estrogen receptor-negative breast cancer. Anticancer Res. 2009;29:871–9.PubMed
6.
Zurück zum Zitat Lauth M, Toftgrd R. The Hedgehog pathway as a drug target in cancer therapy. urr Opin Investig Drugs. 2007;8:457–61. Lauth M, Toftgrd R. The Hedgehog pathway as a drug target in cancer therapy. urr Opin Investig Drugs. 2007;8:457–61.
7.
Zurück zum Zitat Laurendeau I, Ferrer M, Garrido D. Gene expression profiling of the Hedgehog signaling pathway in human meningiomas. Mol Med. 2010, In press. Laurendeau I, Ferrer M, Garrido D. Gene expression profiling of the Hedgehog signaling pathway in human meningiomas. Mol Med. 2010, In press.
8.
Zurück zum Zitat Walter K, Omura N, Hong SM. Overexpression of smoothened activates the sonic hedgehog signaling pathway in pancreatic cancer-associated fibroblasts. Clin Cancer Res. 2010;16:1781–9.PubMedCrossRef Walter K, Omura N, Hong SM. Overexpression of smoothened activates the sonic hedgehog signaling pathway in pancreatic cancer-associated fibroblasts. Clin Cancer Res. 2010;16:1781–9.PubMedCrossRef
9.
Zurück zum Zitat Yanai K, Nagai S, Wada J. Hedgehog signaling pathway is a possible therapeutic target for gastric cancer. J Surg Oncol. 2007;95:55–62.PubMedCrossRef Yanai K, Nagai S, Wada J. Hedgehog signaling pathway is a possible therapeutic target for gastric cancer. J Surg Oncol. 2007;95:55–62.PubMedCrossRef
10.
Zurück zum Zitat Thayer SP, di Magliano MP, Heiser PW. Hedgehog is an early and late mediator of pancreatic cancer tumorigenesis. Nature. 2003;425:851–6.PubMedCrossRef Thayer SP, di Magliano MP, Heiser PW. Hedgehog is an early and late mediator of pancreatic cancer tumorigenesis. Nature. 2003;425:851–6.PubMedCrossRef
11.
Zurück zum Zitat Berman DM, Karhadkar SS, Maitra A. Widespread requirement for Hedgehog ligand stimulation in growth of digestive tract tumours. Nature. 2003;425:846–51.PubMedCrossRef Berman DM, Karhadkar SS, Maitra A. Widespread requirement for Hedgehog ligand stimulation in growth of digestive tract tumours. Nature. 2003;425:846–51.PubMedCrossRef
12.
Zurück zum Zitat Ma X, Chen K, Huang S. Frequent activation of the hedgehog pathway in advanced gastric adenocarcinomas. Carcinogenesis. 2005;26:1698–705.PubMedCrossRef Ma X, Chen K, Huang S. Frequent activation of the hedgehog pathway in advanced gastric adenocarcinomas. Carcinogenesis. 2005;26:1698–705.PubMedCrossRef
13.
Zurück zum Zitat Yoshikawa K, Shimada M, Miyamoto H, Higashijima J, Miyatani T, Nishioka M, et al. Sonic hedgehog relates to colorectal carcinogenesis. J Gastroenterol. 2009;44:1113–7.PubMedCrossRef Yoshikawa K, Shimada M, Miyamoto H, Higashijima J, Miyatani T, Nishioka M, et al. Sonic hedgehog relates to colorectal carcinogenesis. J Gastroenterol. 2009;44:1113–7.PubMedCrossRef
14.
Zurück zum Zitat You S, Zhou J, Chen S, Zhou P, Lv J, Han X, et al. PTCH1, a receptor of Hedgehog signaling pathway, is correlated with metastatic potential of colorectal cancer. Ups J Med Sci. 2010;115:169–75.PubMedCrossRef You S, Zhou J, Chen S, Zhou P, Lv J, Han X, et al. PTCH1, a receptor of Hedgehog signaling pathway, is correlated with metastatic potential of colorectal cancer. Ups J Med Sci. 2010;115:169–75.PubMedCrossRef
15.
Zurück zum Zitat Shi T, Mazumdar T, Devecchio J, Duan ZH, Agyeman A, Aziz M, et al. cDNA microarray gene expression profiling of hedgehog signaling pathway inhibition in human colon cancer cells. PLoS One. 2010; 5. Shi T, Mazumdar T, Devecchio J, Duan ZH, Agyeman A, Aziz M, et al. cDNA microarray gene expression profiling of hedgehog signaling pathway inhibition in human colon cancer cells. PLoS One. 2010; 5.
16.
Zurück zum Zitat Oue T, Yoneda A, Uehara S, Yamanaka H, Fukuzawa M. Increased expression of the hedgehog signaling pathway in pediatric solid malignancies. J Pediatr Surg. 2010;45:387–92.PubMedCrossRef Oue T, Yoneda A, Uehara S, Yamanaka H, Fukuzawa M. Increased expression of the hedgehog signaling pathway in pediatric solid malignancies. J Pediatr Surg. 2010;45:387–92.PubMedCrossRef
17.
Zurück zum Zitat Morishita A, Gong J, Nomura T, Yoshida H, Izuishi K, Suzuki Y, et al. The use of protein array to identify targetable receptor tyrosine kinases for treatment of human colon cancer. Int J Oncol. 2010;37:829–35.PubMedCrossRef Morishita A, Gong J, Nomura T, Yoshida H, Izuishi K, Suzuki Y, et al. The use of protein array to identify targetable receptor tyrosine kinases for treatment of human colon cancer. Int J Oncol. 2010;37:829–35.PubMedCrossRef
18.
Zurück zum Zitat Feason ER, Vogelstein BA. A genetic model of colorectal tumorigenesis. Cell. 1990;61:759–61.CrossRef Feason ER, Vogelstein BA. A genetic model of colorectal tumorigenesis. Cell. 1990;61:759–61.CrossRef
19.
Zurück zum Zitat Nüsslein-Volhard C, Wieschaus E. Mutations affecting segment number and polarity in Drosophila. Nature. 1980;287:795–801.PubMedCrossRef Nüsslein-Volhard C, Wieschaus E. Mutations affecting segment number and polarity in Drosophila. Nature. 1980;287:795–801.PubMedCrossRef
20.
Zurück zum Zitat Ingham PW, McMahon AP. Hedgehog signaling in animal development: paradigms and principles. Genes Dev. 2001;15:3059–87.PubMedCrossRef Ingham PW, McMahon AP. Hedgehog signaling in animal development: paradigms and principles. Genes Dev. 2001;15:3059–87.PubMedCrossRef
21.
Zurück zum Zitat Ramalho-Santos M, Melton DA, McMahon AP. Hedgehog signals regulate multiple aspects of gastrointestinal development. Development. 2000;127:2763–72.PubMed Ramalho-Santos M, Melton DA, McMahon AP. Hedgehog signals regulate multiple aspects of gastrointestinal development. Development. 2000;127:2763–72.PubMed
22.
Zurück zum Zitat Morton JP, Mongeau ME, Klimstra DS. Sonic hedgehog acts at multiple stages during pancreatic tumorigenesis. Proc Natl Acad Sci USA. 2007;104:5103–8.PubMedCrossRef Morton JP, Mongeau ME, Klimstra DS. Sonic hedgehog acts at multiple stages during pancreatic tumorigenesis. Proc Natl Acad Sci USA. 2007;104:5103–8.PubMedCrossRef
23.
Zurück zum Zitat Berman DM, Karhadkar SS, Maitra A. Widespread requirement for Hedgehog ligand stimulation in growth of digestive tract tumors. Nature. 2003;425:846–51.PubMedCrossRef Berman DM, Karhadkar SS, Maitra A. Widespread requirement for Hedgehog ligand stimulation in growth of digestive tract tumors. Nature. 2003;425:846–51.PubMedCrossRef
24.
Zurück zum Zitat Coultas L, Nieuwenhuis E, Anderson GA. Hedgehog regulates distinct vascular patterning events through VEGF dependent and independent mechanisms. Blood. 2010 In press. Coultas L, Nieuwenhuis E, Anderson GA. Hedgehog regulates distinct vascular patterning events through VEGF dependent and independent mechanisms. Blood. 2010 In press.
25.
Zurück zum Zitat Oniscu A, James RM, Morris RG, Bader S, Malcomson RD, Harrison DJ. Expression of Sonic hedgehog pathway genes is altered in colonic neoplasia. J Pathol. 2004;203:909–17.PubMedCrossRef Oniscu A, James RM, Morris RG, Bader S, Malcomson RD, Harrison DJ. Expression of Sonic hedgehog pathway genes is altered in colonic neoplasia. J Pathol. 2004;203:909–17.PubMedCrossRef
26.
Zurück zum Zitat Chatel G, Ganeff C, Boussif N, Delacroix L, Briquet A, Nolens G, et al. Hedgehog signaling pathway is inactive in colorectal cancer cell lines. Int J Cancer. 2007;121:2622–7.PubMedCrossRef Chatel G, Ganeff C, Boussif N, Delacroix L, Briquet A, Nolens G, et al. Hedgehog signaling pathway is inactive in colorectal cancer cell lines. Int J Cancer. 2007;121:2622–7.PubMedCrossRef
Metadaten
Titel
Prognostic value of hedgehog signaling pathway in patients with colon cancer
verfasst von
Meihua Xu
Xinhua Li
Ting Liu
Aimin Leng
Guiying Zhang
Publikationsdatum
01.06.2012
Verlag
Springer US
Erschienen in
Medical Oncology / Ausgabe 2/2012
Print ISSN: 1357-0560
Elektronische ISSN: 1559-131X
DOI
https://doi.org/10.1007/s12032-011-9899-7

Weitere Artikel der Ausgabe 2/2012

Medical Oncology 2/2012 Zur Ausgabe

Adjuvante Immuntherapie verlängert Leben bei RCC

25.04.2024 Nierenkarzinom Nachrichten

Nun gibt es auch Resultate zum Gesamtüberleben: Eine adjuvante Pembrolizumab-Therapie konnte in einer Phase-3-Studie das Leben von Menschen mit Nierenzellkarzinom deutlich verlängern. Die Sterberate war im Vergleich zu Placebo um 38% geringer.

Alectinib verbessert krankheitsfreies Überleben bei ALK-positivem NSCLC

25.04.2024 NSCLC Nachrichten

Das Risiko für Rezidiv oder Tod von Patienten und Patientinnen mit reseziertem ALK-positivem NSCLC ist unter einer adjuvanten Therapie mit dem Tyrosinkinase-Inhibitor Alectinib signifikant geringer als unter platinbasierter Chemotherapie.

Bei Senioren mit Prostatakarzinom auf Anämie achten!

24.04.2024 DGIM 2024 Nachrichten

Patienten, die zur Behandlung ihres Prostatakarzinoms eine Androgendeprivationstherapie erhalten, entwickeln nicht selten eine Anämie. Wer ältere Patienten internistisch mitbetreut, sollte auf diese Nebenwirkung achten.

ICI-Therapie in der Schwangerschaft wird gut toleriert

Müssen sich Schwangere einer Krebstherapie unterziehen, rufen Immuncheckpointinhibitoren offenbar nicht mehr unerwünschte Wirkungen hervor als andere Mittel gegen Krebs.

Update Onkologie

Bestellen Sie unseren Fach-Newsletter und bleiben Sie gut informiert.